Impact of L-Carnitine supplementation for hemodialysis patients with heart failure.
Not Applicable
- Conditions
- hemodialysis patients, heart failure
- Registration Number
- JPRN-UMIN000011498
- Lead Sponsor
- Department of Blood purification, Kidney Center, Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1, A patient with the past of allergy to L-carnitine 2, A pregnant woman or the woman that may have become pregnant 3, The patient who took the supplement of carnitine less than 1 month before registration 4, The patient who judged that a principal investigator was unsuitable as a subject 5, A patient with a high possibility that spring suit medicine will be uncontinuable for six months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eft atrial volume indexed to body surface area, early-to-atrial left ventricular filling ratio, The ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity.
- Secondary Outcome Measures
Name Time Method